Skip to main content
Premium Trial:

Request an Annual Quote

Specialized Genome Data Analysis Centers Awarded $4.8M in NCI Funding

NEW YORK (GenomeWeb) – The National Cancer Institute has awarded $4.8 million to 11 research organizations to fund the establishment of specialized Genome Data Analysis Centers (GDAC) tasked with analyzing data generated by other members of the agency's Genomic Data Analysis Network.

Last year, the NCI announced that it was seeking groups interested in joining the network whose goal is to help the cancer research community develop tools and strategies to study data from large-scale genomics projects.

Among the newly named specialized GDACs are the University of Texas MD Anderson Cancer Center, which received $420,664 in funding to analyze protein expression data from reverse phase protein array data, and $418,519 to address batch effect quality control problems in molecular profiling data analysis; the Broad Institute, which was awarded $472,352 to analyze somatic copy number alteration data; Washington University, which received $391,021 to handle the discovery and clinical interpretation of germline and somatic cancer drivers from network data; and Weill Medical College of Cornell University, which was awarded $489,879 to oversee the functional and clinical interpretation of tumor profile data.

Other specialized GDACs include the University of North Carolina at Chapel Hill, which was awarded $416,184 to conduct RNA sequencing analyses; the BC Cancer Agency, which received $394,335 to perform integrative microRNA data analyses; the Van Andel Research Institute, which was awarded $527,021 to analyze cancer epigenomic data; and Princeton University, which was awarded $376,097 to oversee the pathway and network integration of cancer genomic and clinical data.

Lastly, Oregon Health & Science University received $421,806 to use its data analysis pipelines to support the network; and the University of California, Santa Cruz was awarded $469,457 to develop tools for modeling patient tumors.